According to a new market research study of “Middle East and Africa Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment, Allergy type and Distribution Channel, The Middle East & Africa Allergy immunotherapies market was valued at US$ 137.87 million in 2019 and is projected to reach US$ 297.62 million by 2027; it is expected to grow at a CAGR of 10.2%during the forecast period. The increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations are the key factors fueling the Middle East and Africa allergy immunotherapies market growth.
Based on the treatment, the Middle East and Africa allergy immunotherapies market is further segmented into the SCIT segment held a larger share of the market in 2079. However, the SLIT segment is expected to grow at a higher CAGR during the forecast period. Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. Positive results of various immunotherapies that are in clinical trials encourage the development activities of allergy immunotherapy-based drugs. The market players are also adopting business expansion, collaboration, and new product development strategies to increase their market footprint.
The Middle East and Africa allergy immunotherapy market is anticipated to witness consistent growth in the coming years owing to increasing government expenditures on the healthcare sector for research and development. Additionally, high awareness regarding allergies and treatments available for the same, and increasing need for advanced treatments further pose lucrative growth opportunities to the market players.
HAL Allergy B. V, ALK Abello A/S and Stallergenes Greer are among the leading companies operating in the Middle East and Africa Allergy Immunotherapy market.
The report segments Middle East and Africa Allergy Immunotherapies Market as follows:Reasons to Buy
Based on the treatment, the Middle East and Africa allergy immunotherapies market is further segmented into the SCIT segment held a larger share of the market in 2079. However, the SLIT segment is expected to grow at a higher CAGR during the forecast period. Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. Positive results of various immunotherapies that are in clinical trials encourage the development activities of allergy immunotherapy-based drugs. The market players are also adopting business expansion, collaboration, and new product development strategies to increase their market footprint.
The Middle East and Africa allergy immunotherapy market is anticipated to witness consistent growth in the coming years owing to increasing government expenditures on the healthcare sector for research and development. Additionally, high awareness regarding allergies and treatments available for the same, and increasing need for advanced treatments further pose lucrative growth opportunities to the market players.
HAL Allergy B. V, ALK Abello A/S and Stallergenes Greer are among the leading companies operating in the Middle East and Africa Allergy Immunotherapy market.
The report segments Middle East and Africa Allergy Immunotherapies Market as follows:Reasons to Buy
- Determine prospective investment areas based on a detailed trend analysis of the Middle East & Africa allergy immunotherapy market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different Middle East & Africa allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East & Africa allergy immunotherapy market, providing a clear picture of future opportunities that will help analyse, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East & Africa immunotherapy market.
Table of Contents
1. Introduction
3. Research Methodology
4. Allergy Immunotherapies Market - Market Landscape
5. Allergy immunotherapies Market - Key Market Dynamics
6. Allergy Immunotherapies Market - Middle East and Africa Analysis
7. Allergy Immunotherapies Market Analysis- by Treatment
8. Allergy Immunotherapies Market Analysis- by Allergy Type
9. Allergy Immunotherapies Market Analysis- by Distribution Channel
10. Allergy Immunotherapies Market Analysis and Forecasts to 2027 - Geographical Analysis
11. Impact of COVID-19 Pandemic on Middle East and Africa Allergy Immunotherapies Market
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia